Last update 23 Jan 2025

Vicero Bio

2014|
United States
|
www.vicerobio.com

Overview

Tags

Bispecific antibody
Antibody
Drug conjugates

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Bispecific antibody2
Drug conjugates1
Antibody1
Top 5 TargetCount
CTLA4 x PD-11
PD-1 x VEGFR1
CD205(Lymphocyte antigen 75)1

Related

4
Drugs associated with Vicero Bio
VCR-072
Target-
Mechanism-
Active Org.
Vicero Bio
Originator Org.
Vicero Bio
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
VCR-018
Target
CD205
Mechanism
CD205 inhibitors
Active Org.
Vicero Bio
Originator Org.
Vicero Bio
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
VCR-036
Target
CTLA4 x PD-1
Mechanism
CTLA4 inhibitors [+1]
Active Org.
Vicero Bio
Originator Org.
Vicero Bio
Active Indication-
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Vicero Bio
Login to view more data
0 Patents (Medical) associated with Vicero Bio
Login to view more data
100 Deals associated with Vicero Bio
Login to view more data
100 Translational Medicine associated with Vicero Bio
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
3
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
VCR-018
 ( CD205 )		-
Preclinical
VCR-036
 ( CTLA4 x PD-1 )		-
Preclinical
VCR-072
-
Preclinical
VCR-045
 ( PD-1 x VEGFR )		-
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free